GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Gross-Profit-to-Asset %

LBT Innovations (ASX:LBT) Gross-Profit-to-Asset % : 18.17% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. LBT Innovations's annualized Gross Profit for the quarter that ended in Dec. 2023 was A$1.41 Mil. LBT Innovations's average Total Assets over the quarter that ended in Dec. 2023 was A$7.75 Mil. Therefore, LBT Innovations's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 18.17%.


LBT Innovations Gross-Profit-to-Asset % Historical Data

The historical data trend for LBT Innovations's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBT Innovations Gross-Profit-to-Asset % Chart

LBT Innovations Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.28 3.23 3.23 3.95 8.77

LBT Innovations Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.44 5.34 3.52 13.01 18.17

Competitive Comparison of LBT Innovations's Gross-Profit-to-Asset %

For the Medical Devices subindustry, LBT Innovations's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBT Innovations's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LBT Innovations's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where LBT Innovations's Gross-Profit-to-Asset % falls into.



LBT Innovations Gross-Profit-to-Asset % Calculation

LBT Innovations's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=1.706/( (31.524+7.37)/ 2 )
=1.706/19.447
=8.77 %

LBT Innovations's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1.408/( (7.37+8.125)/ 2 )
=1.408/7.7475
=18.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


LBT Innovations Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of LBT Innovations's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


LBT Innovations (ASX:LBT) Business Description

Traded in Other Exchanges
N/A
Address
16 Anster Street, Adelaide, SA, AUS, 5000
LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines